Member Highlights｜Institute for Biotechnology and Medicine Industry│IBMI

Membership

IBMI

Subject
Grape King Bio reports record sales for last year
Hualien Tzu Chi Hospital, UST collaborate on pioneering telomere study
ENHERTU® Granted Priority Review in the U.S. for Patients with Metastatic HER2 Positive Solid Tumors
Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin's Lymphoma
Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting
【Acepodia】Congratulates Laureates of The 2022 Nobel Prize In Chemistry And Shares The Excitement To Translate Click Chemistry Into A New Class Of Investigational Therapies
Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin’s Lymphoma
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
PharmaEssentia Japan Files Marketing Authorization Application for Ropeginterferon Alfa-2b For the Treatment of Polycythemia Vera
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
Lotus launches generic lenalidomide in 14 countries across Europe under its partner’s label
OBI Pharma signs cancer drug deal with HK’s Odeon
PharmaEssentia welcomes German court ruling, but other side to fight on
Medigen vaccine passes Paraguay trial, earns EUA
Lotus launches the 1st generic of Vinorelbine oral formulation in Taiwan
Advantech Implement First Smart Hospital in Vietnam
Acepodia Strengthens Board of Directors and Scientific Advisory Board with Key Appointments
EtherWAN Systems Awarded IEC 62443 Certification with the Assistance of Bureau Veritas
Acepodia Presents Positive Interim Phase 1 Feasibility Data for Antibody Cell Effector Therapy, ACE1702, in Advanced HER2-Positive Tumors
Bora Pharmaceuticals Partners with KYOWA Pharmaceutical to Manufacture Generic Product for Filing in Japan
Taipei Veterans General Hospital launches a new centre, cancer and inherited disease focused
DCB: Taiwan sees rapid growth of clinical trials in cell therapies
Medigen touts enterovirus vaccine trials
Terry Gou to acquire stake in biotech firm
OBI PHARMA ANNOUNCES POSTER PRESENTATIONS AT AACR 2021 ANNUAL MEETING FOR OBI-3424, OBI-998, GLOBO H AND SSEA-4
TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi
CMIC and DCB Signed MOU for Cooperation Partnership
TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization
Acepodia Presents Data on its Allogeneic Natural Killer-Like Gamma-Delta T Cell Therapy, ACE1831, in Development for Hematological Cancers
Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief Medical Officer and Michael Brock as Chief Strategy Officer
Eisai in partnership with Bristol-Myers in up to $3.1 bln deal to develop cancer drug candidate
UBI-Asia inks COVID-19 vaccine deal with Paraguay
Acer makes headway in SEA markets with VeriSee DR (Diabetic Retinopathy) medical software
TLC and Endo Enter Commercialization Agreement
Oneness Biotech: DFUs treatment approved in Taiwan, aims at global markets by 2030
TLC Announces Details of Stock Swap Transactions
Bora Group's subsidiary Yuta Health becomes Bora Health
Medigen Vaccine Biologics applies to conduct Phase 3 clinical trials in Paraguay
Adimmune sets its first overseas manufacturing site in Indonesia
TCI Bio inks manufacturing deal with US company
BIONET Corp. upbeat on MSC therapy for COVID-19
Meridigen announces compassionate use of new stem cell drug

■ Most Watched

Top 20 biomedical compani...

Taiwan business watch 202...

A Few Years After Launch,...

Net Income of Biomedical ...

■ Industry Watch

Top 20 biomedical compani...

Taiwan business watch 202...

Taiwan biomedical sector ...

MORE...

■ IBMI News

Tech Giants Quanta, ASUS,...

SNQ 2023 Award Ceremony: ...

National Innovation Award...

MORE...

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：16F.-1, No.3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978